Both this novel therapeutic and Semaglutide represent notable advancements in obesity treatment , but they function through slightly different mechanisms. copyright primarily impacts GLP-1 receptors, stimulating insulin release and curbing appetite. Retatrutide is a dual-agonist, impacting both GLP-1 and GIP receptors, which could result in more… Read More